Newsroom

Logos HZI und EMBL
News
Stronger together: EMBL and Helmholtz Health formalise their collaboration in research and development
EMBL and the six Helmholtz Centers of the Research Field Health (Helmholtz Health) are expanding their collaboration. The two research organisations are cooperating to expand the frontiers of health research and advance scientific progress for human health.
22.09.2021
HZI Campus
Einladung
News
TWINCORE Symposium 2021 also digitally successful
On 9 September 2021, the 13th TWINCORE Symposium took place. This year, too, the event was held online due to corona. Nevertheless, the webinar was a great success and attracted even more viewers than last year.
13.09.2021
Schaubild
News
Want some more?
New antibiotics are urgently needed in the fight against multi-resistant bacteria. The recently discovered darobactin is a potential candidate with resistance-breaking properties. This substance shows very good antimicrobial activity against some of the most problematic hospital germs. However, so far darobactin could only be produced in relatively small quantities, making detailed investigation and further development difficult. A team led by Dr Sebastian Groß from the Department of Microbial Natural Products at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken has now addressed this problem. The scientists published their results in the journal Chemical Science.
31.08.2021
HIPS
Einladung
News
Helmholtz Data Science Career Day
Data Scientists are in demand on the job market: all 18 Helmholtz Centers have already advertised several positions calling for skills in AI methods in 2021.
30.08.2021
HZI Campus
Konzept für die nachhaltige Entdeckung und Entwicklung neuer Antibiotika
News
Fighting resistances: Concepts for new antibiotics
Increasingly insensitive to standard drugs: Multi-resistant pathogens are spreading worldwide and even in the near future could threaten the safe treatment of deadly infectious diseases. However, the urgent demand for new antimicrobial agents is offset by a glaring lack of investment into their research. In an article in Nature Reviews Chemistry, the international research alliance IRAADD, which is coordinated by HZI researcher and HIPS director Prof Rolf Müller, presents forward-looking strategies that could be used to solve the problem. Scientists at the German Center for Infection Research (DZIF) are playing a leading role.
20.08.2021
HIPS
Arme und Hände die auf einer Tastatur liegen
News
Claus-Michael Lehr selected as a Scout in the Henriette Herz Programme
The Alexander von Humboldt Foundation has selected Prof Claus-Michael Lehr as a scout within the Henriette Herz Programme.This award allows him to select three young scientific talents from abroad who will work at HIPS for one year as Alexander von Humboldt fellows. In the interview, he explains how this came about and how important international collaboration in science is to him.
11.08.2021
HIPS

HZI in the media

One Health: Forschung in Afrika gegen neue Pandemien

... können wir Pandemien früh erkennen? Forschende des Helmholtz‑Instituts für One Health zeigen, warum Mensch, ...

13.01.2026
|
Deutsche Welle
HIPS und Beiersdorf AG bündeln Kräfte in der Mikrobiom-Forschung

... gewinnbringend eingesetzt werden. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit ...

13.01.2026
|
juraforum.de
Mpox - die Pandemie, über die niemand spricht

... nach SARS-CoV-2, sagt Fabian Leendertz. Er ist Direktor des Helmholtz-Instituts für One Health (HIOH) in ...

13.01.2026
|
Deutsche Welle
Researchers uncover how E coli bacteria sneak into the prostate

from the University Hospital Würzburg (UKW), the Helmholtz Institute for RNA-based Infection Research (HIRI), and University of Münster. The

12.01.2026
|
MSN.com
Wie E. coli in die Prostata gelangt – und wie man ihr die Tür versperrt

... des Universitätsklinikums Würzburg (UKW), des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) und der Universität ...

12.01.2026
|
Biermann Medizin
One Health: Pandemic prevention research in Africa

... potential pandemics early on? Researchers at the Helmholtz Institute for One Health are showing why ...

12.01.2026
|
Deutsche Welle
Jenseits der Genschere: Neuer CRISPR-Mechanismus entdeckt

Entdeckung

 

Forschende am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz- ...

09.01.2026
|
Bionity.COM
Adenovirus: Symptoms, Spread & Protection Tips

tools.” – Dr. Anya Sharma, Virologist at the Helmholtz Centre for Infection Research.

 

Looking Ahead: The Long-Term Implications of

08.01.2026
|
ARCHYDE
CRISPR Cas12a3: A precise tool to halt viral protein production

Beisel at Germany's Helmholtz Institute for RNA-based Infection Research in Würzburg and Dirk Heinz at the Helmholtz Center for Infection

07.01.2026
|
News Medical
Viromed AG: Strategic Update on Operational Focus and Value Creation

consisting of Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, and the Leibniz Institute in

07.01.2026
|
Trading View
Antibiotikaresistenz mit KI-Modellen vorhersagen: Datenverzerrung mindert Zuverlässigkeit

... haben nun die Studienautoren vom HIRI ‒ einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

02.01.2026
|
Biermann Medizin
Mini-Organe vom Roboter: Wie Organoide Tierversuche verringern sollen

... bis zur Medikamentenentwicklung", sagt Josef Penninger, wissenschaftlicher Geschäftsführer des HZI und Leiter der Abteilung Innovative ...

30.12.2025
|
Tagesschau

Register now for the HZI-Newsletter